Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Like PTH treatment, acute YKL-05-099 administration increased renal Cyp27b1 and decreased Cyp24a1 expression and increased circulating 1,25-vitamin D (Figure 1, A and B).

Source: SIK inhibitors increase 1,25-vitamin D in mice by increasing renal Cyp27b1 expression.. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Study design awaiting verification.

Study design awaiting verification

The available source does not establish a sufficiently clear study design.

Meta-analysis unclear · Blinding unclear / not reported · Animal research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

C57BL/6J mice were obtained from The Jackson Laboratory.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis

Study design awaiting verification · The Journal of Clinical Investigation · 2023

Original publication title

A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis

Sung-Hee Yoon; Mark B. Meyer; Carlos Arevalo; Murat Tekguc; Chengcheng Zhang; Jialiang S. Wang; Christian D. Castro Andrade; Katelyn Strauss; Tadatoshi Sato; Nancy A. Benkusky; Seong Min Lee; Rebecca Berdeaux; Marc Foretz; Thomas B. Sundberg; Ramnik J. Xavier; Charles H. Adelmann; Daniel J. Brooks; Anthony Anselmo; Ruslan I. Sadreyev; Ivy A. Rosales; David E. Fisher; Navin Gupta; Ryuji Morizane; Anna Greka; J. Wesley Pike; Michael Mannstadt; Marc N. Wein

© 2023 Yoon et al.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

The renal actions of parathyroid hormone (PTH) promote 1,25-vitamin D generation; however, the signaling mechanisms that control PTH-dependent vitamin D activation remain unknown. Here, we demonstrated that salt-inducible kinases (SIKs) orchestrated renal 1,25-vitamin D production downstream of PTH signaling. PTH inhibited SIK cellular activity by cAMP-dependent PKA phosphorylation. Whole-tissue and single-cell transcriptomics demonstrated that both PTH and pharmacologic SIK inhibitors regulated a vitamin D gene module in the proximal tubule. SIK inhibitors increased 1,25-vitamin D production and renal Cyp27b1 mRNA expression in mice and in human embryonic stem cell: derived kidney organoids.

Global: and kidney-specific Sik2/Sik3 mutant mice showed Cyp27b1 upregulation, elevated serum 1,25-vitamin D, and PTH-independent hypercalcemia. The SIK substrate CRTC2 showed PTH and SIK inhibitor: inducible binding to key Cyp27b1 regulatory enhancers in the kidney, which were also required for SIK inhibitors to increase Cyp27b1 in vivo. Finally, in a podocyte injury model of chronic kidney disease: mineral bone disorder (CKD-MBD), SIK inhibitor treatment stimulated renal Cyp27b1 expression and 1,25-vitamin D production. Together, these results demonstrated a PTH/SIK/CRTC signaling axis in the kidney that controls Cyp27b1 expression and 1,25-vitamin D synthesis.

These findings indicate that SIK inhibitors might be helpful for stimulation of 1,25-vitamin D production in CKD-MBD.

Authors’ abstract

The renal actions of parathyroid hormone (PTH) promote 1,25-vitamin D generation; however, the signaling mechanisms that control PTH-dependent vitamin D activation remain unknown. Here, we demonstrated that salt-inducible kinases (SIKs) orchestrated renal 1,25-vitamin D production downstream of PTH signaling. PTH inhibited SIK cellular activity by cAMP-dependent PKA phosphorylation. Whole-tissue and single-cell transcriptomics demonstrated that both PTH and pharmacologic SIK inhibitors regulated a vitamin D gene module in the proximal tubule. SIK inhibitors increased 1,25-vitamin D production and renal Cyp27b1 mRNA expression in mice and in human embryonic stem cell: derived kidney organoids.

Global: and kidney-specific Sik2/Sik3 mutant mice showed Cyp27b1 upregulation, elevated serum 1,25-vitamin D, and PTH-independent hypercalcemia. The SIK substrate CRTC2 showed PTH and SIK inhibitor: inducible binding to key Cyp27b1 regulatory enhancers in the kidney, which were also required for SIK inhibitors to increase Cyp27b1 in vivo. Finally, in a podocyte injury model of chronic kidney disease: mineral bone disorder (CKD-MBD), SIK inhibitor treatment stimulated renal Cyp27b1 expression and 1,25-vitamin D production. Together, these results demonstrated a PTH/SIK/CRTC signaling axis in the kidney that controls Cyp27b1 expression and 1,25-vitamin D synthesis.

These findings indicate that SIK inhibitors might be helpful for stimulation of 1,25-vitamin D production in CKD-MBD.

Publication and source details

Original title: A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis

Sung-Hee Yoon; Mark B. Meyer; Carlos Arevalo; Murat Tekguc; Chengcheng Zhang; Jialiang S. Wang; Christian D. Castro Andrade; Katelyn Strauss; Tadatoshi Sato; Nancy A. Benkusky; Seong Min Lee; Rebecca Berdeaux; Marc Foretz; Thomas B. Sundberg; Ramnik J. Xavier; Charles H. Adelmann; Daniel J. Brooks; Anthony Anselmo; Ruslan I. Sadreyev; Ivy A. Rosales; David E. Fisher; Navin Gupta; Ryuji Morizane; Anna Greka; J. Wesley Pike; Michael Mannstadt; Marc N. Wein

The Journal of Clinical Investigation · 2023

Address correspondence to: Marc N. Wein, 55 Fruit Street, Boston, Massachusetts 02114, USA. Phone: 617.643.0204; Email: mnwein@mgh.harvard.edu.

Authorship note: MBM and CA contributed equally to this work.

© 2023 Yoon et al.2023Yoon et al.https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. National Institute of Diabetes and Digestive and Kidney Diseaseshttps://doi.org/10.13039/100000062 P01DK011794,R01DK116716 National Institute of Arthritis and Musculoskeletal and Skin Diseaseshttps://doi.org/10.13039/100000069 P30 AR066261,R01AR072304,R01AR043369 National Cancer Institutehttps://doi.org/10.13039/100000054 P01CA163222,R01CA222871 National Institute of Diabetes and Digestive and Kidney Diseaseshttps://doi.org/10.13039/100000062 DK133821,DK126023Funding to MNWFunding to RM

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T07:15:59.038145+00:00

DOI: 10.1172/jci163627 · PMC10145948